查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942488

2026年全球乳房切片市场报告

Breast Biopsy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，乳房切片市场经历了显着成长，预计到2025年将达到15.3亿美元，到2026年将达到16.5亿美元，复合年增长率为7.5%。过去几年成长要素包括：先进切片检查系统应用有限、依赖传统外科切片检查技术、乳癌发病率上升、医院和诊断中心基础设施扩建以及超音波引导手术的普及。

预计未来几年乳房切片市场将维持强劲成长，2030年市场规模将达到21.7亿美元，复合年增长率（CAGR）为7.2%。预测期内的成长主要归功于液态生物检体和影像引导系统的技术进步、早期乳癌筛检意识的提高、诊断中心和医院的扩张、人工智慧和数据分析的日益普及，以及个人化和精准医疗方法的开发。预测期内的关键趋势包括：微创切片检查技术的日益普及、液态生物检体技术的广泛应用、影像引导切片检查系统的成长、乳癌诊断和筛检项目的扩展，以及对患者安全和检体准确性的日益重视。

预计乳癌发病率的上升将推动乳房切片市场在未来持续成长。乳癌是一种起源于乳腺组织细胞的恶性肿瘤，若不及时治疗，癌细胞会扩散至身体其他部位。乳癌发生率的上升与预期寿命延长、筛检和诊断技术的进步以及公众对该疾病认知度的提高等因素密切相关。乳癌乳房切片是指从可疑的乳房区域采集组织样本，以确诊并确定癌症的类型。例如，根据美国非营利组织Breastcancer.org预测，截至2025年10月，预计将有316,950名女性被诊断出患有侵袭性乳癌，同时也将报告约59,080例新的导管原位癌（DCIS）病例。因此，乳癌发生率的上升正在推动乳房切片市场的扩张。

乳房切片标记物市场的主要企业正致力于开发创新产品，例如超音波可见定位标记物，以提高病灶定位的准确性并减少乳房切片过程中标记物的移位。超音波可见定位标记物是一种可植入装置，可在诊断影像过程中增强切片检查部位的可见性，同时确保未来手术介入的稳定定位。例如，总部位于美国的乳房切片和立体定位技术供应商Mamotome于2023年8月推出了HydroMark Plus。这款乳房切片定位标记可提高超音波下病灶的可见性，帮助放射科医师和外科医师进行精准定位，同时最大限度地降低后续手术过程中标记物移位的风险。作为Mamotome HydroMark产品系列的最新成员，HydroMark Plus旨在提高手术可靠性，预计今年稍后在美国全国上市。其主要特点包括：超音波可见性高、在乳房组织内移动幅度小，以及与各种乳房摄影诊断和介入工作流程相容，有助于改善临床疗效和提高手术可靠性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球乳房切片市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创切片检查技术的应用日益广泛
    • 液态生物检体技术的使用日益增多
    • 影像引导切片检查系统的发展
    • 扩大乳癌诊断和筛检项目
    • 更加重视病人安全和检体准确性

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 诊断中心
  • 研究所
  • 肿瘤中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球乳房切片市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球乳房切片市场规模、对比及成长率分析
  • 全球乳房切片市场表现：规模与成长，2020-2025年
  • 全球乳房切片市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 切片穿刺针、导引系统、切片检查、立体定位导丝、检测试剂盒、液态生物检体设备等。
  • 透过影像引导技术
  • 磁振造影（MRI）引导乳房切片、超音波引导乳房切片、乳房X光摄影引导立体定位切片检查、电脑断层扫描（CT）引导切片检查及其他影像引导技术
  • 透过检查程序
  • 乳房切片（针刺切片）、乳房切片（开腹手术）、乳房切片（液态生物检体）
  • 透过使用
  • 医院、诊所、诊断中心和其他应用
  • 按类型细分：切片穿刺针
  • 核心切片穿刺针、细针穿刺（FNA）针、真空辅助切片穿刺针、自动切片穿刺针
  • 按类型细分：导引系统
  • 超音波引导系统、MRI引导系统、立体定位引导系统、断层合成引导系统
  • 按类型细分：切片检查
  • 可调节切片检查台、专用切片检查、相容影像诊断的切片检查
  • 按类型细分：立体定位导线
  • 钩线定位装置、辐射导引定位线、磁性种子定位系统
  • 依类型细分：检测试剂盒
  • 乳癌检测试剂盒、生物标记检测试剂盒、乳癌基因检测套组
  • 按类型细分：液态生物检体设备
  • 循环性肿瘤细胞（CTC）分离装置、血浆DNA分离试剂盒、液态生物检体分析系统
  • 按类型细分：其他类型
  • 切片检查黏合剂、检体采集和运输装置、病患管理系统

第十章 区域与国家分析

  • 全球乳房切片市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球乳房切片市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 乳房切片市场：竞争格局与市场份额，2024 年
  • 乳房切片市场：公司估值矩阵
  • 乳房切片市场：公司概况
    • Siemens Healthineers AG
    • Fujifilm Holdings Corporation
    • Becton Dickinson and Company BD
    • Koninklijke Philips
    • GE HealthCare Technologies Inc

第37章：其他领先和创新企业

  • Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年乳房切片市场：提供新机会的国家
  • 2030年乳房切片市场：充满新机会的细分市场
  • 2030年乳房切片市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MBBIO04_G26Q1

A breast biopsy is a procedure in which a small sample of breast tissue is removed and examined under a microscope to determine whether it is cancerous or benign. It is usually performed when a lump or abnormality is detected through imaging or a physical exam, and it can be done using different techniques such as needle biopsy or surgical biopsy, often guided by imaging methods such as ultrasound or mammography.

The major types of breast biopsy products include biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Biopsy needles are specialized medical instruments designed to collect breast tissue samples for diagnostic evaluation. The image-guided technologies include MRI-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic biopsy, CT-guided biopsy, and others, while the procedures involve needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. These are applied in hospitals, clinics, diagnostic centers, and other settings.

Tariffs are impacting the breast biopsy market by increasing the cost of imported biopsy needles, imaging guidance systems, and liquid biopsy instruments. Segments such as MRI-guided and stereotactic biopsy systems are particularly affected, with major manufacturing regions in Asia-Pacific, including China and India, facing higher import duties. This has led to elevated production and procurement costs, as well as delayed adoption in some regions. On the positive side, tariffs are encouraging local manufacturing, innovation in alternative devices, and investment in domestic production capacities.

The breast biopsy market research report is one of a series of new reports from The Business Research Company that provides breast biopsy market statistics, including breast biopsy industry global market size, regional shares, competitors with a breast biopsy market share, detailed breast biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the breast biopsy industry. This breast biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast biopsy market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, adoption of ultrasound-guided procedures.

The breast biopsy market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to technological advancements in liquid biopsy and imaging-guided systems, rising awareness of early breast cancer detection, expansion of diagnostic centers and hospitals, increasing integration of ai and data analytics, development of personalized and precision medicine approaches. Major trends in the forecast period include increasing adoption of minimally invasive biopsy procedures, rising use of liquid biopsy techniques, growth in imaging-guided biopsy systems, expansion of breast cancer diagnostic and screening programs, enhanced focus on patient safety and sample accuracy.

The growing prevalence of breast cancer is anticipated to support the expansion of the breast biopsy market going forward. Breast cancer is a malignant tumor that develops in the cells of breast tissue and may spread to other parts of the body if not treated in a timely manner. The increasing prevalence of breast cancer is linked to factors such as longer life expectancy, improved screening and detection techniques, and heightened awareness of the disease. Breast biopsy procedures are used to extract tissue samples from suspicious breast areas to confirm diagnoses and determine cancer characteristics. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, an estimated 316,950 women were projected to be diagnosed with invasive breast cancer in 2025, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast biopsy market.

Leading companies operating in the breast biopsy marker market are focusing on developing innovative products, such as ultrasound-visible site markers, to improve lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is an implantable device designed to enhance visualization of biopsy sites during imaging while providing stable localization for future surgical interventions. For example, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This breast biopsy site marker improves lesion visibility under ultrasound, supporting accurate targeting by radiologists and surgeons while minimizing the risk of marker migration during subsequent surgical procedures. As the latest addition to Mammotome's HydroMark portfolio, HydroMark Plus is engineered for improved procedural reliability and was scheduled for nationwide availability in the US by year-end. Its key features include high ultrasound conspicuity, reduced movement within breast tissue, and compatibility with a wide range of breast imaging and interventional workflows, supporting improved clinical outcomes and procedural confidence.

In May 2024, Lunit Inc., a South Korea-based medical software company, acquired Volpara Health Technologies Ltd. for an undisclosed amount. Through this acquisition, Lunit enhances its portfolio with advanced breast imaging and analytics technologies, strengthening its capabilities in early cancer detection. Volpara Health Technologies Ltd. is a New Zealand-based provider of breast biopsy solutions.

Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.

North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast biopsy market consists of revenues earned by providing services such as biopsy procedures, consultations, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast biopsy market also includes sales of biodegradable tissue markers, and semi-automated and fully automated biopsy needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Biopsy Needles; Guidance Systems; Biopsy Tables; Localization Wires; Assay Kits; Liquid Biopsy Instruments; Other Types
  • 2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy; Ultrasound Guided Breast Biopsy; Mammography Guided Stereotactic Biopsy; Computed Tomography (CT) Guided Biopsy; Other Image Guided Technologies
  • 3) By Procedure: Needle Breast Biopsy; Open Surgical Breast Biopsy; Liquid Breast Biopsy
  • 4) By Application: Hospitals; Clinics; Diagnostic Centers; Other Applications
  • Subsegments:
  • 1) By Biopsy Needles: Core Biopsy Needles; Fine Needle Aspiration (FNA) Needles; Vacuum-Assisted Biopsy Needles; Automatic Biopsy Needles
  • 2) By Guidance Systems: Ultrasound Guidance Systems; MRI Guidance Systems; Stereotactic Guidance Systems; Tomosynthesis Guidance Systems
  • 3) By Biopsy Tables: Adjustable Biopsy Tables; Specialty Biopsy Tables; Imaging-Compatible Biopsy Tables
  • 4) By Localization Wires: Hookwire Localization Devices; Radioguided Localization Wires; Magnetic Seed Localization Systems
  • 5) By Assay Kits: Breast Cancer Assay Kits; Biomarker Detection Kits; Genetic Testing Kits for Breast Cancer
  • 6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices; Plasma DNA Isolation Kits; Liquid Biopsy Analysis Systems
  • 7) By Other Types: Biopsy Adhesives; Specimen Collection and Transport Devices; Patient Management Systems
  • Companies Mentioned: Siemens Healthineers AG; Fujifilm Holdings Corporation; Becton Dickinson and Company BD; Koninklijke Philips; GE HealthCare Technologies Inc; Hologic Inc; Merit Medical Systems; Argon Medical Devices; Canon Medical Systems Corporation; Devicor Medical Products Inc; Planmed Oy; Menarini-Silicon Biosystems; Seno Medical Instruments Inc; Dilon Technologies Inc; INRAD Inc; Promaxo Inc; Cook Medical LLC; Boston Scientific Corporation; Stryker Corporation; Intact Medical Corporation; Scion Medical Technologies LLC; Galini SRL; Ethicon Surgical Technologies; Encapsule Medical Devices LLC; Cardinal Health Inc; Olympus Corporation; F Hoffmann-La Roche Ltd; Biocept Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Breast Biopsy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Breast Biopsy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Breast Biopsy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Breast Biopsy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Biopsy Procedures
    • 4.2.2 Rising Use Of Liquid Biopsy Techniques
    • 4.2.3 Growth In Imaging-Guided Biopsy Systems
    • 4.2.4 Expansion Of Breast Cancer Diagnostic And Screening Programs
    • 4.2.5 Enhanced Focus On Patient Safety And Sample Accuracy

5. Breast Biopsy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Centers
  • 5.4 Research Laboratories
  • 5.5 Oncology Centers

6. Breast Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Breast Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Breast Biopsy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Breast Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Breast Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Biopsy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Biopsy Market Segmentation

  • 9.1. Global Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
  • 9.2. Global Breast Biopsy Market, Segmentation By Image Guided Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
  • 9.3. Global Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
  • 9.4. Global Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Centers, Other Applications
  • 9.5. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
  • 9.6. Global Breast Biopsy Market, Sub-Segmentation Of Guidance Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
  • 9.7. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Tables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
  • 9.8. Global Breast Biopsy Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
  • 9.9. Global Breast Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
  • 9.10. Global Breast Biopsy Market, Sub-Segmentation Of Liquid Biopsy Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
  • 9.11. Global Breast Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

10. Breast Biopsy Market Regional And Country Analysis

  • 10.1. Global Breast Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Breast Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Biopsy Market

  • 11.1. Asia-Pacific Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Biopsy Market

  • 12.1. China Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Biopsy Market

  • 13.1. India Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Biopsy Market

  • 14.1. Japan Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Biopsy Market

  • 15.1. Australia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Biopsy Market

  • 16.1. Indonesia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Biopsy Market

  • 17.1. South Korea Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Biopsy Market

  • 18.1. Taiwan Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Biopsy Market

  • 19.1. South East Asia Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Biopsy Market

  • 20.1. Western Europe Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Biopsy Market

  • 21.1. UK Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Biopsy Market

  • 22.1. Germany Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Biopsy Market

  • 23.1. France Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Biopsy Market

  • 24.1. Italy Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Biopsy Market

  • 25.1. Spain Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Biopsy Market

  • 26.1. Eastern Europe Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Biopsy Market

  • 27.1. Russia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Biopsy Market

  • 28.1. North America Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Biopsy Market

  • 29.1. USA Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Biopsy Market

  • 30.1. Canada Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Biopsy Market

  • 31.1. South America Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Biopsy Market

  • 32.1. Brazil Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Biopsy Market

  • 33.1. Middle East Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Biopsy Market

  • 34.1. Africa Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Biopsy Market Regulatory and Investment Landscape

36. Breast Biopsy Market Competitive Landscape And Company Profiles

  • 36.1. Breast Biopsy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Breast Biopsy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Breast Biopsy Market Company Profiles
    • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson and Company BD Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. GE HealthCare Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Breast Biopsy Market Other Major And Innovative Companies

  • Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation

38. Global Breast Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Biopsy Market

40. Breast Biopsy Market High Potential Countries, Segments and Strategies

  • 40.1 Breast Biopsy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Breast Biopsy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Breast Biopsy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer